|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Scott Page as an advisor to the Company’s board of directors. Page brings over 38 years of commercial banking experience to Assure. Currently, he is president of Lobo Consulting, which provides a variety of consulting services to small and mid-sized companies, including debt and capital structuring, strategic planning and executive coaching.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the Rocky Mountain Microcap Conference III, which is being held on October 9, 2018, at the Ameristar Resort in Black Hawk, CO. For more information about the conference or to schedule a one-on-one meeting with Assure management, please contact your Rocky Mountain Microcap representative, or Assure’s investor relations team at IOM@liolios.com. Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announces that it has issued an aggregate of 500,000 options to purchase common shares of the Company (the “Options”) to officers, employees, directors and consultants of the Company. Each of the Options issued will be exercisable at US$1.80 (equivalent to C$2.33, based on the noon exchange rate set by the Bank of Canada on September 28, 2018). 20% of each option issuance will vest immediately and one sixth of the balance will vest every 6 months thereafter.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Trent Carman as chief financial officer, effective October 22nd, 2018. Carman comes to Assure with more than 20 years of CFO experience, including over 15 years of healthcare industry expertise for both public and private organizations. Most recently he served as CFO for Vivos Therapeutics and prior to that was CFO at Air Methods Corp. (formerly Nasdaq: AIRM) for over 13 years.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has performed its first neuromonitoring case in the state of Pennsylvania. The move into Pennsylvania represents the fourth new state Assure has added to its platform since branching out from its home state of Colorado just last November. This rapid expansion has been driven by Assure’s scalable neuromonitoring platform, as well as the Company’s strong relationships and focus on service.
–Revenue Increases by 46% to $6.0 Million, Net Income Increases to $3.3 Million–. –Management to Discuss Second Quarter Results via Conference Call on Thursday, August 30, 2018, at 11:00 A.M. Eastern Time–. ...
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Thursday, August 30, 2018, at 11:00 a.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2018. The company will report its financial results in a press release prior to the conference call. Assure’s Executive Chairman and Interim CEO John Farlinger and Founder Preston Parsons will host the conference call, followed by a question and answer period.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the 7th Annual Liolios Gateway Conference, which is being held September 5-6, 2018 at the Four Seasons Hotel in San Francisco, CA. The presentation will be webcast live and available for replay here and on the Gateway Conference website at www.gateway-conference.com/presenters. The 7th Annual Gateway Conference is an invite-only conference presented by Liolios, a full-service financial communications firm.
OTCQB: ARHH), a provider of intraoperative neuromonitoring services, is pleased to announce that it has received a notice from the TSX Venture Exchange (the “Exchange”) that its shares will be reinstated for trading on Friday August 24, 2018. Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided.
–Revenue Increases by 86% to $5.7 Million, Net Income up 30% to $3.0 Million–. –Management to Discuss First Quarter Results via Conference Call on Monday, August 20, 2018, at 11:30 A.M. Eastern Time–. ...
OTCQB: ARHH), a provider of intraoperative neuromonitoring services announces that it expects to file unaudited financial statements and management discussion & analysis (MD&A) for the first quarter ended March 31, 2018 (the “First Quarter Filings”), with the British Columbia Securities Commission (the “BCSC”) and on www.sedar.com on or before August 17, 2018. As disclosed yesterday, the Company reported financial results and filed its annual audited financial statements for the year ended December 31, 2017 and restated audited financial statements for the year ended December 31, 2016 (the “Audited Statements”).
PARKER, Colo., Aug. 07, 2018-- Assure Holdings Corp., a provider of intraoperative neuromonitoring services, reported financial results for the 12 months ended December 31, 2017 and restated results for ...
Assure Holdings Corp. (the “Company” or “Assure”) (IOM.V) (ARHH) is providing an update relating to the appointment of its new auditor and an update relating to the Management Cease Trade Order (“MCTO”), effective May 1, 2018, previously applied for and granted by the British Columbia Securities Commission (the “BCSC”) in anticipation that the Company would not meet the filing deadline for its audited annual financial statements, management discussion and analysis (“MD&A”) and CEO and CFO certificates for the year ended December 31, 2017 (the “2017 Annual Filings”) in accordance with National Instrument 51-102 Continuous Disclosure Requirements. The BCSC confirmed an extension to the MCTO allowing the Company until August 3, 2018 to file the 2017 Annual Filings and interim unaudited financial statements and MD&A for the three-month ended March 31, 2018 (the “Q1 2018 Interim Statements”).